2018 - Fellow, National Academy of Inventors
Member of the Association of American Physicians
Drew M. Pardoll mostly deals with Immunology, Immune system, T cell, Cell biology and Antigen. His Cancer research extends to Immunology, which is thematically connected. His Immune system research is multidisciplinary, incorporating perspectives in Receptor, Cancer research and Antibody.
His T cell study combines topics from a wide range of disciplines, such as Cytotoxic T cell, T lymphocyte, CD8 and Immune tolerance. His studies deal with areas such as Transcription factor, MHC class I, Major histocompatibility complex, Macrophage polarization and Antigen presentation as well as Cell biology. The study incorporates disciplines such as Recombinant DNA and Virology in addition to Antigen.
His primary scientific interests are in Immunology, Cancer research, Immune system, Immunotherapy and T cell. His Immunology study incorporates themes from Cancer and Cytotoxic T cell. His Cancer research research is multidisciplinary, relying on both Immune checkpoint, Prostate cancer and Carcinogenesis.
He has researched Immune system in several fields, including Signal transduction and Antibody. His study in Immunotherapy is interdisciplinary in nature, drawing from both Blockade, Oncology and Glioma. His research integrates issues of Molecular biology, Receptor, Immune tolerance and Cell biology in his study of T cell.
The scientist’s investigation covers issues in Cancer research, Immunotherapy, Immune system, Immune checkpoint and Cancer. His Cancer research research includes elements of T cell, Cytotoxic T cell and Prostate cancer. His T cell study incorporates themes from Cell culture, Antigen and Cancer immunology.
Drew M. Pardoll studies Immune system, focusing on Antigen presentation in particular. His Cancer research integrates issues from Medical physics, Mutant and Oncology. His studies deal with areas such as Immunology, Receptor and Avidity as well as Transfection.
His primary areas of study are Cancer research, Immune system, Immunotherapy, Tumor microenvironment and Internal medicine. His Cancer research study combines topics from a wide range of disciplines, such as Cell, Biological activity, In vitro, Cytokine and Immunity. His Immune system research is multidisciplinary, relying on both Extracellular matrix, Signal transduction, Cell biology and Regenerative medicine.
The study incorporates disciplines such as T cell, Blockade, Melanoma and Antigen in addition to Immunotherapy. His T cell research incorporates elements of Dendritic cell and Cancer immunology. Drew M. Pardoll interconnects Small interfering RNA, Gene knockdown, In vivo and Cancer immunotherapy in the investigation of issues within Tumor microenvironment.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells.
Tianhong Wang;Guilian Niu;Marcin Kortylewski;Lyudmila Burdelya.
Nature Medicine (2004)
Expression of Programmed Death 1 Ligands by Murine T Cells and APC
Tomohide Yamazaki;Hisaya Akiba;Hideyuki Iwai;Hironori Matsuda.
Journal of Immunology (2002)
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
Eric V. Dang;Joseph Barbi;Huang Yu Yang;Huang Yu Yang;Dilini Jinasena.
Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
Seng Ryong Woo;Meghan E Turnis;Monica V Goldberg;Jaishree Bankoti.
Cancer Research (2012)
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity.
Marcin Kortylewski;Maciej Kujawski;Tianhong Wang;Sheng Wei.
Nature Medicine (2005)
B7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells
Su Yi Tseng;Mizuto Otsuji;Kevin Gorski;Xin Huang.
Journal of Experimental Medicine (2001)
Does the Immune System See Tumors as Foreign or Self
Annual Review of Immunology (2003)
The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
Nicolas J. Llosa;Michael Cruise;Ada Tam;Elizabeth C. Wicks.
Cancer Discovery (2015)
The role of CD4+ T cell responses in antitumor immunity
Drew M Pardoll;Suzanne L Topalian.
Current Opinion in Immunology (1998)
A fixed site of DNA replication in eucaryotic cells
Drew M. Pardoll;Bert Vogelstein;Donald S. Coffey.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: